1 of 2
Global Biopharmaceuticals Manufacturing Consumables Testing Market to Reach $797.1 Million by 2027
Amid the COVID-19 crisis, the global market for Biopharmaceuticals Manufacturing Consumables Testing estimated at US$390.7 Million in the year 2020, is projected to reach a revised size of US$797.1 Million by 2027, growing at a CAGR of 10.7% over the analysis period 2020-2027. Compendial & Multi Compendial Laboratory Testing, one of the segments analyzed in the report, is projected to record a 10.3% CAGR and reach US$404.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Laboratory Testing segment is readjusted to a revised 10.9% CAGR for the next 7-year period.
The U.S. Market is Estimated at $105.6 Million, While China is Forecast to Grow at 14.1% CAGR
The Biopharmaceuticals Manufacturing Consumables Testing market in the U.S. is estimated at US$105.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$170 Million by the year 2027 trailing a CAGR of 14.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.5% and 9.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.
Custom Testing / Customer Proprietary Testing Segment to Record 12.1% CAGR
In the global Custom Testing / Customer Proprietary Testing segment, USA, Canada, Japan, China and Europe will drive the 11.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$29.6 Million in the year 2020 will reach a projected size of US$62.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$115.8 Million by the year 2027, while Latin America will expand at a 13.6% CAGR through the analysis period.
Select Competitors (Total 33 Featured):
Amid the COVID-19 crisis, the global market for Biopharmaceuticals Manufacturing Consumables Testing estimated at US$390.7 Million in the year 2020, is projected to reach a revised size of US$797.1 Million by 2027, growing at a CAGR of 10.7% over the analysis period 2020-2027. Compendial & Multi Compendial Laboratory Testing, one of the segments analyzed in the report, is projected to record a 10.3% CAGR and reach US$404.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Laboratory Testing segment is readjusted to a revised 10.9% CAGR for the next 7-year period.
The U.S. Market is Estimated at $105.6 Million, While China is Forecast to Grow at 14.1% CAGR
The Biopharmaceuticals Manufacturing Consumables Testing market in the U.S. is estimated at US$105.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$170 Million by the year 2027 trailing a CAGR of 14.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.5% and 9.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.
Custom Testing / Customer Proprietary Testing Segment to Record 12.1% CAGR
In the global Custom Testing / Customer Proprietary Testing segment, USA, Canada, Japan, China and Europe will drive the 11.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$29.6 Million in the year 2020 will reach a projected size of US$62.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$115.8 Million by the year 2027, while Latin America will expand at a 13.6% CAGR through the analysis period.
Select Competitors (Total 33 Featured):
- Activation Laboratories Ltd.
- Agilent Technologies
- Albany Molecular Research Inc.
- Alcami Corporation
- Avance Biosciences
- Avomeen Analytical Services
- BioSpectra
- Boston Analytical
- Catalent, Inc.
- Charles River
Note: Product cover images may vary from those shown
2 of 2
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
- UNITED STATES
- CANADA
- JAPAN
- CHINA
- EUROPE
- FRANCE
- GERMANY
- ITALY
- UNITED KINGDOM
- SPAIN
- RUSSIA
- REST OF EUROPE
- ASIA-PACIFIC
- AUSTRALIA
- INDIA
- SOUTH KOREA
- REST OF ASIA-PACIFIC
- LATIN AMERICA
- ARGENTINA
- BRAZIL
- MEXICO
- REST OF LATIN AMERICA
- MIDDLE EAST
- IRAN
- ISRAEL
- SAUDI ARABIA
- UNITED ARAB EMIRATES
- REST OF MIDDLE EAST
- AFRICA
- Total Companies Profiled: 33
Note: Product cover images may vary from those shown
